Bank of Montreal
EBAC

Bank of Montreal’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Bank of Montreal’s Portfolio EBAC Stock Details EBAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,325
Closed -$271 – 4472
2022
Q3 		$271 Buy
+27,325
New +$270K ﹤0.01% 3003

Other funds holding EBAC

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

Bank of Montreal's EBAC Position: Q4 2022 in Review

Bank of Montreal sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q4 2022, closing a stake of 27,325 shares — an estimated $271 sold.

Bank of Montreal first reported a position in EBAC in Q3 2022 and held it in 1 quarter. The position peaked at $271 in Q3 2022. 50 funds tracked by Wall St. Rank hold EBAC as of Q4 2022.

  • Bank of Montreal reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 27,325 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q4 2022, an estimated $271.
  • Bank of Montreal first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q3 2022 and held it in 1 quarter.
  • Bank of Montreal's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $271 in Q3 2022.
  • 50 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.